134 results
8-K
EX-99.2
HZNP
Horizon Therapeutics Public Ltd Co
8 Aug 23
Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results
7:11am
Property and ESG NMOSD: Neuromyelitis optica spectrum disorder. | ESG: Environmental, social and governance.
Horizon is a Leading High-Growth … KRYSTEXXA UPLIZNA Our Pipeline Rare Disease Medicines, Intellectual Property and ESG ESG: Environmental, social and governance.
TED and How TEPEZZA
DEFA14A
7n48 ag4eyzju8q7jkar
12 Dec 22
Additional proxy soliciting materials
5:00pm
8-K
EX-2.1
f00zay6k8mnx
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
8-K
EX-99.2
6put3dywqcluj16dxo31
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
8-K
EX-99.3
omapwdewnlwe80cbrq
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
8-K
EX-99.1
e5v3u5g809toflb
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
DEFA14A
m8e mtju1m
12 Dec 22
Additional proxy soliciting materials
6:31am
8-K
EX-99.1
1ztpxp5da22y
2 Nov 22
Results of Operations and Financial Condition
7:06am
8-K
EX-99.1
7tno3l t9as1
3 Aug 22
Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance
7:06am
8-K
EX-99.1
n8rj0m9cytgu038 az6
29 Apr 22
Departure of Directors or Certain Officers
7:22pm